MCLEAN, Va.--(BUSINESS WIRE)--Somatus, the market leader in value-based kidney care, today announced that Dr. Nwamaka Eneanya has joined the Company as Senior Scientific Advisor. Dr. Eneanya will guide clinical research studies to advance the Company’s evidence-based approach to care delivery for patients with or at-risk of developing kidney disease.
Dr. Eneanya is a nationally and internationally recognized clinical investigator with research interests that focus on health equity among patients with advanced and end-stage kidney disease. Her work has been supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), National Institute on Minority Health and Health Disparities (NIMHD), and the American Society of Nephrology.
“As Somatus continues to grow and deliver care to more than 30,000 patients, across the country, Dr. Eneanya’s leadership and passion for kidney health and equity will be critical,” said Somatus Chief Executive Officer, Dr. Ikenna Okezie. “With her guidance and expertise, we can accelerate the impact of the Somatus care model using evidence-based research to improve the quality and experience of care for patients with kidney disease in the communities we serve.”
“The mission of Somatus is one that I immediately identified with,” said Dr. Nwamaka Eneanya. “My career and research are rooted in the belief that all patients with or at-risk of kidney disease deserve to receive the best integrated care. I am honored to join the team revolutionizing the kidney care industry and look forward to helping Somatus use research and data to advance their model and mission.”
Dr. Eneanya is an attending nephrologist and Assistant Professor of Medicine and Epidemiology at the University of Pennsylvania. She is also the Director of Health Equity, Anti-Racism and Community Engagement in the Nephrology Division. Dr. Eneanya completed her nephrology training at the combined Nephrology Fellowship Program at Massachusetts General Hospital/Brigham and Women’s Hospital and residency in internal medicine at Brigham and Women’s Hospital. She holds an undergraduate degree from Cornell University, medical degree from Meharry Medical College, and master’s degree in public health from the Harvard T.H. Chan School of Public Health.
Somatus partners with leading health plans, health systems, and nephrology and primary care groups to provide integrated care for patients with or at risk of developing kidney disease. As the market leader in value-based kidney care, Somatus' vertically integrated clinical services and technology delay or prevent disease progression, improve quality and care coordination, and increase the use of home dialysis modalities and rates of kidney transplantation. The company is headquartered in McLean, Virginia, and founded by a team of world-class healthcare operators, successful entrepreneurs, and leading clinicians treating kidney disease. For more information, please visit www.somatus.com.